Atlas Trials

Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State

Clinical trial NCT02223065 · COMPLETED

Trial details

NCT number
NCT02223065
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2014-09-01
Primary completion
2014-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.